ES2173477T3 - Derivados de tetrahidronaftaleno y su utilizacion terapeutica. - Google Patents

Derivados de tetrahidronaftaleno y su utilizacion terapeutica.

Info

Publication number
ES2173477T3
ES2173477T3 ES97939057T ES97939057T ES2173477T3 ES 2173477 T3 ES2173477 T3 ES 2173477T3 ES 97939057 T ES97939057 T ES 97939057T ES 97939057 T ES97939057 T ES 97939057T ES 2173477 T3 ES2173477 T3 ES 2173477T3
Authority
ES
Spain
Prior art keywords
tetrahydronaftaleno
derivatives
therapeutic use
compounds
selectines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97939057T
Other languages
English (en)
Inventor
Richard John Kenneth Taylor
Paul Vincent Murphy
John Gary Montana
David Thomas Manallack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Darwin Discovery Ltd
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Application granted granted Critical
Publication of ES2173477T3 publication Critical patent/ES2173477T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems

Abstract

LA INVENCION SE REFIERE A COMPUESTOS DE FORMULA (I), DONDE R 1 ES UN RESIDUO DE FUCOSA O DE MANOSA. DICHOS COMPUESTOS PRESENTAN UNA UTILIDAD TERAPEUTICA A TRAVES DE LA INHIBICION DE SELECTINAS Y, POR TANTO, DE LA ADHESION CELULAR.
ES97939057T 1996-09-05 1997-09-05 Derivados de tetrahidronaftaleno y su utilizacion terapeutica. Expired - Lifetime ES2173477T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9618520.2A GB9618520D0 (en) 1996-09-05 1996-09-05 Compounds and their therapeutic use

Publications (1)

Publication Number Publication Date
ES2173477T3 true ES2173477T3 (es) 2002-10-16

Family

ID=10799452

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97939057T Expired - Lifetime ES2173477T3 (es) 1996-09-05 1997-09-05 Derivados de tetrahidronaftaleno y su utilizacion terapeutica.

Country Status (11)

Country Link
US (1) US6133240A (es)
EP (1) EP0931086B1 (es)
JP (1) JP2001500490A (es)
AT (1) ATE217006T1 (es)
AU (1) AU707160B2 (es)
CA (1) CA2264737A1 (es)
DE (1) DE69712351T2 (es)
ES (1) ES2173477T3 (es)
GB (1) GB9618520D0 (es)
WO (1) WO1998009977A1 (es)
ZA (1) ZA978015B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7060685B2 (en) 2002-05-16 2006-06-13 Glycomimetics, Inc. Compounds and methods for inhibiting selectin-mediated function
CA2490703A1 (en) * 2002-07-03 2004-01-15 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis
US20040219158A1 (en) * 2003-05-02 2004-11-04 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
JP2007524658A (ja) * 2003-11-19 2007-08-30 グリコミメティクス， インコーポレイテッド Ｅ−およびｐ−セレクチンの両方のための糖模倣物アンタゴニスト
WO2005051920A2 (en) * 2003-11-19 2005-06-09 Glycomimetics, Inc. Specific antagonist for both e- and p-selectins
WO2006127906A1 (en) * 2005-05-25 2006-11-30 Glycomimetics, Inc. Heterobifunctional compounds for selectin inhibition
CA2618638C (en) * 2005-08-09 2014-03-11 Glycomimetics, Inc. Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
JP5209476B2 (ja) 2005-09-02 2013-06-12 グリコミメティクス， インコーポレイテッド ヘテロ二官能性全セレクチン阻害剤
US20090176717A1 (en) * 2006-06-01 2009-07-09 Glycomimetics, Inc. Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
JP5298020B2 (ja) 2006-10-12 2013-09-25 グリコミメティクス， インコーポレイテッド ヘキソースおよびｎ−アセチルヘキソサミンの糖模倣体置換
NZ598863A (en) * 2007-02-09 2013-11-29 Glycomimetics Inc Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
US8039442B2 (en) * 2007-07-18 2011-10-18 Glycomimetics, Inc. Compounds and methods for treatment of sickle cell disease or complications associated therewith
US8895510B2 (en) 2008-04-08 2014-11-25 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
WO2009152245A1 (en) 2008-06-13 2009-12-17 Glycomimetics, Inc. Treatment of cancers of the blood using selected glycomimetic compounds
WO2010126888A1 (en) * 2009-05-01 2010-11-04 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
US8921328B2 (en) 2010-09-14 2014-12-30 Glycomimetics, Inc. E-selectin antagonists
ES2655443T7 (es) 2011-12-22 2021-03-22 Glycomimetics Inc Compuestos antagonistas de E-selectina
CA2891514C (en) 2012-12-07 2020-08-25 Glycomimetics, Inc. Compounds, compositions and methods using e-selectin antagonists for mobilization of hematopoietic cells
CN107108679B (zh) 2014-12-03 2020-10-23 糖模拟物有限公司 E-选择蛋白和cxcr4趋化因子受体的异双官能抑制剂
CA3009836A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
WO2017151708A1 (en) 2016-03-02 2017-09-08 Glycomimetics, Inc. Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
US11433086B2 (en) 2016-08-08 2022-09-06 Glycomimetics, Inc. Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
JP7069136B2 (ja) 2016-10-07 2022-05-17 グリコミメティクス， インコーポレイテッド 極めて強力な多量体ｅ－セレクチンアンタゴニスト
JP7272956B2 (ja) 2017-03-15 2023-05-12 グリコミメティクス， インコーポレイテッド Ｅ－セレクチンアンタゴニストとしてのガラクトピラノシル－シクロヘキシル誘導体
US11712446B2 (en) 2017-11-30 2023-08-01 Glycomimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
CN111566117A (zh) 2017-12-29 2020-08-21 糖模拟物有限公司 E-选择蛋白和半乳凝素-3的异双功能抑制剂
AU2019230013A1 (en) 2018-03-05 2020-09-10 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
USD936390S1 (en) * 2021-04-23 2021-11-23 Qingdao Jinxiang Tongzhen Textile Co., Ltd. Wedge pillow set
USD936391S1 (en) * 2021-04-26 2021-11-23 Qingdao Jinxiang Tongzhen Textile Co., Ltd. Wedge pillow set

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639734A (en) * 1994-12-20 1997-06-17 Esko; Jeffrey D. Disaccharide inflammation inhibitors and uses thereof

Also Published As

Publication number Publication date
ZA978015B (en) 1998-09-07
GB9618520D0 (en) 1996-10-16
ATE217006T1 (de) 2002-05-15
AU707160B2 (en) 1999-07-01
DE69712351D1 (de) 2002-06-06
DE69712351T2 (de) 2002-11-07
EP0931086A1 (en) 1999-07-28
CA2264737A1 (en) 1998-03-12
AU4128297A (en) 1998-03-26
US6133240A (en) 2000-10-17
WO1998009977A1 (en) 1998-03-12
EP0931086B1 (en) 2002-05-02
JP2001500490A (ja) 2001-01-16

Similar Documents

Publication Publication Date Title
ES2173477T3 (es) Derivados de tetrahidronaftaleno y su utilizacion terapeutica.
PT1193270E (pt) Pirrolobenzodiazepinas
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
ATE306261T1 (de) Antithrombosemittel
ATE171068T1 (de) Chinoloncarbonsäurederivate, ihre herstellung und ihre verwendung als zelladhäsion inhibitoren
DE59709414D1 (de) Oxyiminopregnancarbolactone
DE69709938T2 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
FI902555A0 (fi) Diarylstyrylkinolindisyror.
ATE231149T1 (de) (1,8)-naphthyridinderivate derivate mit antiviraler wirkung
DK0923568T5 (da) Hidtil ukendte benzofuran-4-carboxamider
DE69722656D1 (de) Bicyclische arylcarboxamide und ihre therapeutische verwendung
PT918776E (pt) Sintese total de acilfulvenos antitumorais
IT1285770B1 (it) Composti corticoidei
ES2157992T3 (es) Alcoxi-alquil-carbamatos de imidazo(1,2-a)piridinas.
ES2077071T3 (es) Derivados de quinolin-3-carboxamida.
GB9725750D0 (en) Compound
MXPA03001081A (es) Medicamento anti-inflamatorio.
NO986086D0 (no) FremgangsmÕte for fremstilling av 17-estere av 9<alfa>,21-dihalo-pregnan-11
GR1002883B (el) Νεα παραγωγα της 2, 3-βενζοδιαζεπινης
NZ332840A (en) 1-[2-(pyridin-2-ylmethoxy)pyridin-5ylcarbamoyl]-indoline derivatives
RS50033B (sr) Derivati etansulfonil-piperidina
NZ333854A (en) Intermediates for the preparation of 2-imidazoline-5-ones
ES2134563T3 (es) Cianofenilsulfenil halogenuro y su utilizacion en el procedimiento de preparacion de benzoisotiazol 3-sustituido.
FI930092A (fi) Indanopyrrolidinkarbamater
ES2001676A6 (es) Procedimiento para la preparacion de derivados propionamidinos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 931086

Country of ref document: ES